Non-protuberant Lesions and Diagnostic Delays in Dermatofibrosarcoma Protuberans: A Single Institutional Retrospective Analysis

Authors

  • Jun Akome Department of Dermatology of Osaka University Graduate School of Medicine, Suita, Osaka, Japan
  • Yosuke Ishitsuka Department of Dermatology of Osaka University Graduate School of Medicine, Suita, Osaka, Japan
  • Atsushi Tanemura Department of Dermatology of Osaka University Graduate School of Medicine, Suita, Osaka, Japan
  • Tateki Kubo Department of Plastic Surgery of Osaka University Graduate School of Medicine, Suita, Osaka, Japan
  • Manabu Fujimoto Department of Dermatology of Osaka University Graduate School of Medicine, Suita, Osaka, Japan

DOI:

https://doi.org/10.2340/actadv.v104.41234

Keywords:

Dermatofibroma protuberans, Clinical diagnosis, Optimization of treatment outcomes

Abstract

Abstract is missing (Short communication)

Downloads

Download data is not yet available.

References

Hoesly PM, Lowe GC, Lohse CM, Brewer JD, Lehman JS. Prognostic impact of fibrosarcomatous transformation in dermatofibrosarcoma protuberans: a cohort study. J Am Acad Dermatol 2015; 72: 419-425.

https://doi.org/10.1016/j.jaad.2014.11.020 DOI: https://doi.org/10.1016/j.jaad.2014.11.020

Martin L, Piette F, Blanc P, Mortier L, Avril MF, Delaunay MM, et al. Clinical variants of the preprotuberant stage of dermatofibrosarcoma protuberans. Br J Dermatol 2005; 153: 932-936.

https://doi.org/10.1111/j.1365-2133.2005.06823.x DOI: https://doi.org/10.1111/j.1365-2133.2005.06823.x

Llombart B, Serra-Guillen C, Rubio L, Nagore E, Requena C, Traves V, et al. Subcutaneous dermatofibrosarcoma protuberans, a rare subtype with predilection for the head: a retrospective series of 18 cases. J Am Acad Dermatol 2017; 77: 503-511 e501.

https://doi.org/10.1016/j.jaad.2017.02.046 DOI: https://doi.org/10.1016/j.jaad.2017.02.046

David MP, Funderburg A, Selig JP, Brown R, Caliskan PM, Cove L, et al. Perspectives of patients with dermatofibrosarcoma protuberans on diagnostic delays, surgical outcomes, and nonprotuberance. JAMA Netw Open 2019; 2: e1910413.

https://doi.org/10.1001/jamanetworkopen.2019.10413 DOI: https://doi.org/10.1001/jamanetworkopen.2019.10413

Kesserwan C, Sokolic R, Cowen EW, Garabedian E, Heselmeyer-Haddad K, Lee CC, et al. Multicentric dermatofibrosarcoma protuberans in patients with adenosine deaminase-deficient severe combined immune deficiency. J Allergy Clin Immunol 2012; 129: 762-769 e761.

https://doi.org/10.1016/j.jaci.2011.10.028 DOI: https://doi.org/10.1016/j.jaci.2011.10.028

Published

2024-09-24

How to Cite

Akome, J., Ishitsuka, Y., Tanemura, A., Kubo, T., & Fujimoto, M. (2024). Non-protuberant Lesions and Diagnostic Delays in Dermatofibrosarcoma Protuberans: A Single Institutional Retrospective Analysis. Acta Dermato-Venereologica, 104, adv41234. https://doi.org/10.2340/actadv.v104.41234

Issue

Section

Short Communication

Categories